A Trial Investigating the Effect of Probenecid and Ciclosporin on the Pharmacokinetics of SNAC in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 20 Jul 2018
At a glance
- Drugs Semaglutide (Primary) ; Ciclosporin; Probenecid
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 16 Jul 2018 Status changed from active, no longer recruiting to completed.
- 04 Jul 2018 Planned End Date changed from 10 Aug 2018 to 13 Jul 2018.
- 04 Jul 2018 Planned primary completion date changed from 10 Aug 2018 to 13 Jul 2018.